Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics

Epilepsy, a neurological illness, is characterized by recurrent uncontrolled seizures. There are many treatments of options that can be used as the therapy of epilepsy. However, anti-seizure medications as the primary treatment choice for epilepsy show many possible adverse effects and even pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: de Liyis, Bryan Gervais, Tandy, Sevinna Geshie, Endira, Joana Fourta, Putri, Komang Andjani, Utami, Desak Ketut Indrasari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589779/
https://www.ncbi.nlm.nih.gov/pubmed/36310854
http://dx.doi.org/10.1186/s41983-022-00557-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589779/
https://www.ncbi.nlm.nih.gov/pubmed/36310854
http://dx.doi.org/10.1186/s41983-022-00557-8

Ejemplares similares